Company creates Younger T Cells for fighting cancer using its NR2F6 technology
The company is focused on therapies such as skinceuticals, gastroenterology, neuropsychiatry, cardiac diabetes care etc.
Sun Pharma will receive from Cassiopea the exclusive right to develop and commercialize WINLEVI in Japan, Australia, New Zealand, Brazil, Mexico and Russia.
The funds raised in the seed round will be used for research and development of Shri Chyawan Ayurved Product
An algorithm based testing for Fatty Liver Disease
Fermentation-based manufacturing leverages Evonik’s biotechnology platform
The array available for a subscription includes popular products to make menstrual hygiene a regular practice and extend further affordability to its users
Bringing next-gen cannabinoid therapeutics to cancer patients
Amarex Clinical Research guides its client to phase II of FDA trials
Dupixent is the first and only biologic medicine approved to treat moderate-to-severe atopic dermatitis from infancy to adulthood
Subscribe To Our Newsletter & Stay Updated
